Viking Global Investors

Kavitha Dasu Named Battelle Inventor of the Year

Retrieved on: 
Monday, May 15, 2023
Other Manufacturing, Environment, Research, Chemicals, Plastics, Environmental Health, Manufacturing, Green Technology, Other Science, Science, SARS-CoV-2, Tyndall Air Force Base, Organization, Community, GAC, Viking Global Investors, Cosmetics, PFAS, The Puzzle Solver

Battelle has honored Kavitha Dasu as the 2022 Inventor of the Year.

Key Points: 
  • Battelle has honored Kavitha Dasu as the 2022 Inventor of the Year.
  • Three years ago, Dasu was honored with Battelle’s Emerging Scientist award.
  • “We know our employees as Solvers at Battelle, and she’s a prime example.
  • Senior Administrative Assistant Ronni Coppock won the Community Involvement Award for her work with organizations around Tyndall Air Force Base.

Revive Environmental’s PFAS Annihilator™ Technology Recognized With Two Honors from Fast Company 2023 World Changing Ideas Awards

Retrieved on: 
Thursday, May 4, 2023
Environment, Other Energy, Chemicals, Plastics, Environmental Health, Utilities, Manufacturing, Sustainability, Green Technology, Energy, Education, PFAS, Politics, Nature, Water, Climate, AI, Health, Viking Global Investors, Cosmetics

Revive Environmental’s PFAS Annihilator™ has been awarded two recognitions from Fast Company’s 2023 World Changing Ideas Awards announced this week.

Key Points: 
  • Revive Environmental’s PFAS Annihilator™ has been awarded two recognitions from Fast Company’s 2023 World Changing Ideas Awards announced this week.
  • In the first full-scale, commercial deployment, the PFAS Annihilator™ is handling more than 100,000 gallons of concentrated waste per day.
  • Revive Environmental is a water treatment technology spin-out company co-founded by Battelle and Viking Global Investors.
  • For more information about Revive Environmental, visit www.revive-environmental.com and to learn more about Battelle, visit www.battelle.org .

Revive Environmental PFAS Annihilator™ Deployed in First-to-Market Commercial Destruction of “Forever Chemicals”

Retrieved on: 
Monday, May 1, 2023
Chemicals, Plastics, Environment, Utilities, Manufacturing, Green Technology, Energy, Foam, AFFF, Human, Partnership, Firefighting foam, PFAS, Engineering, Paint, Food, Carbon, Global Investors Summit, EPA, Food packaging, Animal, Soil, Battelle, Incineration, Water, GAC, Health, Viking Global Investors, Cosmetics, Landfill, Environmental remediation, Revive

The PFAS Annihilator is answering America’s burgeoning PFAS contamination problem and even comes with a certificate of destruction.

Key Points: 
  • The PFAS Annihilator is answering America’s burgeoning PFAS contamination problem and even comes with a certificate of destruction.
  • In 2021, the U.S. Environmental Protection Agency (EPA) identified more than 120,000 U.S. locations where people may be exposed to PFAS.
  • Since that demonstration, Battelle developed a full-scale version of the PFAS Annihilator and realized the need to get to market with speed, so it launched Revive Environmental.
  • Battelle transferred to Revive patented technologies— PFAS Annihilator​ and GAC Renew™​ —to isolate, remove and destroy PFAS chemicals in aqueous waste streams and other sources of contamination.

GPS Rebrands as “Thredd” to Reflect Its Unique Position as the Go to Payments Partner of Innovators Worldwide

Retrieved on: 
Thursday, April 27, 2023
Technology, Payments, Finance, Security, Fintech, Banking, Electronic Commerce, Professional Services, Software, Digital Cash Management, Digital Assets, Heart, DNA, Partnership, Life, BNPL, Allianz Global Investors, Visa, Temasek, Mastercard, As a service, Advent International, Growth, Ecosystem, Travel, Viking Global Investors, Financial services

Thredd is known for its customer-centred approach to enable payments innovators to launch new card programmes quickly, easily, and cost effectively.

Key Points: 
  • Thredd is known for its customer-centred approach to enable payments innovators to launch new card programmes quickly, easily, and cost effectively.
  • Thredd has created a unique niche as a hands-on, modern processor providing reliable digital payment processing capabilities, including real-time, bespoke card management tools, reporting, and world-class fraud prevention technology.
  • Thredd is the processing partner of choice for an array of verticals, including digital banking, Buy Now Pay Later (BNPL), Travel, and Banking-as-a-Service (BaaS).
  • “Our new brand reflects our renewed focus on enabling our clients to create a more interconnected, accessible, and seamless payments ecosystem.

Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer

Retrieved on: 
Thursday, April 20, 2023
Oncology, Health, Radiology, Research, Science, Pharmaceutical, Biotechnology, PK, Carcinoma, Drug development, Doctor of Philosophy, Investment, Radionuclide, Venture round, Beta, Food, Therapeutic index, ADMAR, Viking Global Investors, Cancer, Bone marrow, Record, Radiochemistry, Radiopharmaceutical, Antibody, Terra Venture Partners, SCLC, AbCellera, DLL3, Protein, Patient, Kidney, Neoplasm, FDA, Therapy, IND, Regulation of tobacco by the U.S. Food and Drug Administration, FC, Radio, Isotope, Medical imaging, Management

Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals for cancer, today announced it has raised $142 million in combined Series A and B financing.

Key Points: 
  • Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals for cancer, today announced it has raised $142 million in combined Series A and B financing.
  • “Abdera’s ROVEr™ platform enables the design of antibody-based radiopharmaceuticals that are ideally suited to specific cancer targets with optimized PK properties to pair with a radioisotope of choice and maximize therapeutic impact.
  • “DLL3 is a well-validated target for SCLC, a cancer with few treatment options,” said Yvonne Yamanaka, Ph.D., principal, venBio Partners.
  • “We are pleased to have worked with the company’s talented co-founders to grow Abdera and we look forward to what this team can achieve.

IGM Financial, a Member of the Power Corporation Group of Companies, Making Long-Term Strategic Investment in Rockefeller Capital Management; Becomes Shareholder Alongside Majority Investor Viking Global Investors

Retrieved on: 
Monday, April 3, 2023
Asset Management, Professional Services, Finance, Partnership, Power Corporation of Canada, Mackenzie Investments, Optimism, Education, IGM, Rockefeller Capital Management, Wealthsimple, Orientation, China Asset Management, Desmarais, Allianz Global Investors, Wachtell, Lipton, Rosen & Katz, Philosophy, Rockefeller family, Retirement, Fleming, Growth, Viking Global Investors, Financial services, Management, Vikings

Rockefeller Capital Management today announced a minority investment in the company by IGM Financial Inc. (“IGM Financial”), a member of the Power Corporation of Canada (“Power Corporation”) group of companies.

Key Points: 
  • Rockefeller Capital Management today announced a minority investment in the company by IGM Financial Inc. (“IGM Financial”), a member of the Power Corporation of Canada (“Power Corporation”) group of companies.
  • “We are very pleased that IGM Financial is becoming a strategic investor in the firm, alongside Viking Global Investors, our founding majority investor, and the Rockefeller family,” said Gregory J. Fleming, President & CEO of Rockefeller Capital Management.
  • In addition, as part of this transaction, the Rockefeller family is increasing its investment in Rockefeller Capital Management.
  • “We are thrilled and enthusiastically support this coming together of Power Corporation, IGM Financial, Rockefeller Capital Management, Viking Global Investors, and the Rockefeller family,” said Paul Desmarais Jr. and André Desmarais, Chairman and Deputy Chairman, respectively, of Power Corporation.

ID.me Appoints Samantha Greenberg as Chief Financial Officer and Raises $132 Million in Series D Funding

Retrieved on: 
Tuesday, April 11, 2023
Auctus, Citadel, Treasury, Bloomberg Businessweek, Stanford University, Identity theft, Postgraduate education, Business, MBA, ID.me, Allianz Global Investors, Goldman Sachs, CNBC, M&A, Wharton School of the University of Pennsylvania, Stanford Graduate School of Business, Ernst & Young, Stanford University centers and institutes, Paulson, CapitalG, Commerce, Widener University Commonwealth Law School, Growth, CFO, Joseph M. Katz Graduate School of Business, Government, Institutional investor, Woman, Conference, Viking Global Investors, Economics, Institutional Investor, Cryptocurrency

MCLEAN, Va., April 11, 2023 /PRNewswire/ -- ID.me, the secure digital identity network with more than 100 million members , announced today the appointment of Samantha Greenberg as Chief Financial Officer.

Key Points: 
  • MCLEAN, Va., April 11, 2023 /PRNewswire/ -- ID.me, the secure digital identity network with more than 100 million members , announced today the appointment of Samantha Greenberg as Chief Financial Officer.
  • Greenberg brings to ID.me over 20 years of experience leading financial operations, analyzing private and public technology and consumer companies, and scaling high-growth businesses.
  • The latest round brings the total investment in the company to more than $240 million since its founding in 2010.
  • Samantha is joining our team at the right time, after we closed our Series D funding and surpassed 100 million members.

AlphaSense Raises $100M Led By Alphabet's CapitalG to Fuel Innovation in AI and Market Intelligence

Retrieved on: 
Tuesday, April 11, 2023
Partnership, B2B, Goldman Sachs, Research, Allianz Global Investors, Bank of America, Acquisition, Investment, Collection, Alphabet, Growth capital, AI, Bank, News, Viking Global Investors, CapitalG, Sales, Retail, Merck

NEW YORK, April 11, 2023 /PRNewswire/ -- AlphaSense, the leading market intelligence and search platform, today announced a $100 million addition to its $225 million Series D financing round at a $1.8 billion valuation through new investments by CapitalG, Alphabet's independent growth fund, and existing investors, including the Growth Equity business within Goldman Sachs Asset Management (Goldman Sachs) and Viking Global Investors.

Key Points: 
  • The company's subscriber base has more than doubled in the past year, reflecting the business and financial world's heightened need for market intelligence to navigate through the current economic environment.
  • This investment will fuel continued deployment of AlphaSense's advanced AI capabilities, including generative AI that dramatically speeds up the research process for business and financial professionals.
  • "We are proud to support AlphaSense as it powers market intelligence and research for the business world," said James Luo, Partner at CapitalG.
  • Recent examples include AlphaSense's 2021 acquisition of Stream , the world's broadest library of expert interview transcripts, and a 2022 acquisition of Sentieo , a financial intelligence platform.

Pragma Bio Secures $10M From The Venture Collective, Merck Global Health Innovation Fund, Viking Global, and CJ Investments To Expand Its Proprietary Technology Platform To Discover Novel Medicines

Retrieved on: 
Thursday, March 23, 2023
Health, Technology, Software, General Health, Research, Science, Pharmaceutical, Archive, Therapy, Investment, Bio, Enzyme, Biomarker, Genetic code, Assam Global Investors' Summit, Collection, Nature, Patient, Immune system, Drug discovery, Artificial intelligence, Synthetic biology, Viking Global Investors, Pharmaceutical industry, Lattice, Pragma

The Venture Collective, led the round joined by investors Viking Global Investors, Merck Global Health Innovation Fund and CJ Investments (Korean-based strategic investor).

Key Points: 
  • The Venture Collective, led the round joined by investors Viking Global Investors, Merck Global Health Innovation Fund and CJ Investments (Korean-based strategic investor).
  • Pragma Bio is utilizing patient data to explore the synergistic bond between nature's chemistry found in the human body and the immune system with the goal of discovering novel medicines.
  • Furthermore, Pragma Bio has assembled a team of world-renowned drug hunters that have successfully generated over $30 billion in exits and commercialized medicines.
  • Pragma Bio is built upon the concept of bringing program code and genetic code to life in a pragmatic fashion.

CNM LLP Appoints Bill Strong as President to Lead Global Business Operations and Strategic Growth

Retrieved on: 
Tuesday, March 7, 2023
Professional Services, Security, Technology, Other Technology, Finance, Consulting, Accounting, Culture, Upfront Ventures, Viking Global Investors, Temasek, Apeel Sciences, Growth, Idealab, Global Investors Summit, Face, Orange County Business Journal, GIC, Mental health, Love, CNM, World Bank Group, Information technology, Ernst & Young, Financial services, Nursing, Management

CNM LLP, a leading technical advisory firm, has named seasoned finance, operations, and corporate development executive Bill Strong as its first ever President.

Key Points: 
  • CNM LLP, a leading technical advisory firm, has named seasoned finance, operations, and corporate development executive Bill Strong as its first ever President.
  • In this position, Strong will collaborate with CNM’s Managing Partner Sanjay Sheth to further develop the firm’s personnel and culture while spearheading global business operations and strategic initiatives to support the firm’s continued growth.
  • “Bill is the ideal candidate to bring CNM to the next level,” said CNM Executive Chair and Founder Nathan Matthews.
  • “Bill’s vast knowledge of finance and expertise in global operations and corporate development will make him an undeniable force at CNM,” said Sheth.